Atrial fibrillation (AF) is the most common cardiac arrhythmia and often involves reentrant electrical activation (e.g. spiral waves). Drug therapy for AF can have serious side effects including proarrhythmia, while electrical shock therapy is associated with discomfort and tissue damage. Hypothetically, forced expression and subsequent activation of light-gated cation channels in cardiomyocytes might deliver a depolarizing force sufficient for defibrillation, thereby circumventing the aforementioned drawbacks. We therefore investigated the feasibility of light-induced spiral wave termination through cardiac optogenetics.
Introduction
Atrial fibrillation (AF) is the most common cardiac rhythm disorder in clinical practice, substantially contributing to morbidity and mortality, especially in the elderly. 1 Yet, knowledge about its underlying mechanisms remains far from complete, although reentrant conduction is widely accepted to play a prominent role in AF. Still, current treatment of AF is suboptimal. 1 -3 To convert AF to normal cardiac rhythm, drug treatment and/or electrical cardioversion are being employed. Drug treatment is rather ineffective and may have dangerous side effects such as the occurrence of ventricular arrhythmias, while electrical cardioversion is associated with tissue damage and serious discomfort. This makes the use of external or implantable cardioverter/defibrillator devices in AF treatment undesirable, as most patients would require multiple shocks per day causing electrical cardioversion to serve as a last resort treatment modality only. 4 Hence, a search for an effective, but less painful and shockless method of cardioversion is warranted. Electrical cardioversion relies on synchronous depolarization of large areas of the atrial myocardium, in order to terminate the reentrant conduction underlying fibrillation. 5 In theory, shockfree cardioversion might be elicited by genetically modifying the atrial cardiomyocytes to express depolarizing cation channels that are activated through other means than electroshock, granted that the endogenous electrochemical gradients provide sufficient depolarizing force. Recently, optogenetics has been introduced as a method combining genetic engineering with light stimulation to control, with very high spatial and temporal resolution, specific cellular properties, 6 including the membrane potential of excitable cells. 7 -9 To this end, light-gated ion channels from the microbial opsin family are expressed in target cells like cardiomyocytes or neurons, and subsequently activated by light of defined wavelengths to generate a controllable ion current. This strategy has previously been proved to be effective for light-induced pacing of ventricular cardiomyocytes following the forced expression of depolarizing light-gated channels in these cells. 8 Hence, optogenetics might provide a feasible combination of cation channels and mode of activation to achieve shockfree cardioversion. Still, it is unknown whether optogenetic engineering of atrial cardiomyocytes (aCMCs) allows for light-induced termination of fibrillation maintained by reentrant spiral waves. Therefore, we investigated whether by optogenetic modification of aCMCs, a depolarizing photocurrent (i.e. an ion current elicited by light) could be generated sufficiently strong to terminate reentrant conduction in monolayer cultures of these cells. To this purpose, we employed Ca 2+ -translocating channelrhodopsin (CatCh), 10 an ultrasensitive light-gated cation channel, and a blue (470 nm) light-emitting diode (LED)-based light source for its activation. The effects of CatCh activation on reentrant conduction were investigated by voltagesensitive dye and multi-electrode array (MEA) mapping in a 2D monolayer model of spiral wave reentry using neonatal rat aCMCs. 11 
Methods

Animal studies
All animal experiments were approved by the Animal Experiments Committee of the Leiden University Medical Center and conformed to the Guide for the Care and Use of Laboratory Animals as stated by the US National Institutes of Health.
Cell isolation and culture
Neonatal rat aCMCs were isolated as described previously. 11 Briefly, 2-day-old Wistar rats were anaesthetized by 5% isoflurane inhalation and adequate anaesthesia was confirmed by the absence of reflexes. Hearts were rapidly excised and atria were carefully separated from the ventricles. Next, atrial tissue was minced and dissociated with collagenase type 1 (450 U/mL; Worthington, Lakewood, NJ, USA) and DNase I (18,75 Kunitz/ mL; Sigma-Aldrich, St Louis, MO, USA) and pre-plated on Primaria-coated cell-culture dishes (Becton Dickinson, Breda, the Netherlands) for 120 min to allow selective attachment of non-myocytes (mainly cardiac fibroblasts). Unattached cells (mainly aCMCs) were seeded in 24-well cell-culture plates (Corning Life Sciences, Amsterdam, the Netherlands) containing fibronectin (Sigma-Aldrich)-coated, round glass coverslips (15 mm diameter). Cell densities of 0.5-8×10 5 cells/well were used depending on the assay. At Day 1 of culture, cells were incubated with Mitomycin-C (10 mg/mL; SigmaAldrich) for 2 h, as described previously. 12 The culture medium, which consisted of Dulbecco's modified Eagle's medium/HAM's F10 (1 : 1, v/v; Life Technologies, Bleiswijk, the Netherlands) supplemented with 5% horse serum (Life Technologies), was refreshed daily and cells were cultured in a humidified incubator at 378C and 5% CO 2 .
Construction of self-inactivating lentiviral vector shuttle plasmids
The CatCh-encoding self-inactivating lentiviral vector (SIN-LV) shuttle plasmid pLV-CaMKIIa-hChR2(L132C)-eYFP.WPRE was kindly provided by the Stanford Optogenetics Resource Center (http://www.stanford.edu/ group/dlab/optogenetics). To allow generation of SIN-LVs directing highlevel CatCh expression in aCMCs, the murine calcium/calmodulin-dependent protein kinase II alpha promotor in pLV-CaMKIIa-hChR2(L132C)-eYFP. WPRE was replaced by a polymerase chain reaction (PCR) fragment encoding the striated muscle-specific MHCK7 promotor. 13 The MHCK7 promoter was amplified with VELOCITY DNA polymerase (GC Biotech, Alphen aan den Rijn, the Netherlands) from a derivative of plasmid LV.DPRE.pA+. MHCK7.Luc 14 using deoxyribonucleotides A117 (5 ′ CCTTAATTAACCC TTCAGATTAAAAATAACTGA 3 ′ ) and A118 (5 ′ TTACCGGTGCTGGC TGGCTCCTGA 3 ′ ; Sigma-Aldrich) as forward and reverse primer, respectively. Subcloning was done using the restriction enzymes PacI and AgeI-HF (both from New England Biolabs, Ipswich, MA, USA), recognition sequences of which were introduced at both ends of the MHCK7 promoter fragment by the PCR procedure. This yielded the SIN-LV shuttle plasmid pLV.MHCK7.C atCh eYFP.WHVPRE. For making a negative control vector, pLV.MHC K7.CatCh eYFP.WHVPRE was incubated with AgeI-HF and BoxI (Thermo Fisher Scientific, Waltman, MA, USA), treated with Klenow polymerase (Thermo Fisher Scientific) and the resulting 10.0 kb DNA fragment was selfligated yielding pLV.MHCK7.eYFP.WHVPRE. The correctness of the SIN-LV shuttle constructs was verified by restriction mapping with five different enzymes and by partial nucleotide sequence analysis using the Quick Shot sequencing services of BaseClear (Leiden, the Netherlands). For large-scale purification of the SIN-LV shuttle and packaging plasmids, the JETSTAR 2.0 Plasmid Maxiprep kit (Genomed, Löhne, Germany) was used following the instructions of the manufacturer.
SIN-LV production
LV.CatCh eYFP and LV.eYFP particles were produced from the SIN-LV shuttle plasmids pLV.MHCK7.CatCh eYFP.WHVPRE and pLV.MHCK7. eYFP.WHVPRE, respectively, using a previously described method. 11 The concentrated vector suspensions were aliquoted in 100 mL portions and stored at 2808C until use. aCMCs were transduced at Day 4 of culture by adding vector suspension directly to the culture medium. After 18 h, cells were washed once with phosphate-buffered saline (PBS) and given fresh culture medium. The SIN-LVs were applied at doses that resulted in the transduction of essentially all aCMCs. Transduction level was assessed by enhanced yellow fluorescent protein (eYFP) visualization with an Axiovert 200 M inverse fluorescence microscope (Carl Zeiss, Sliedrecht, the Netherlands). 
Immunocytology
Optical mapping
To analyse the electrophysiological effect of CatCh-generated photocurrents on aCMC cultures, cells were assayed by optical mapping on Day 7 or 8 of culture. Action potential (AP) propagation was visualized using the voltage-sensitive dye di-4-ANEPPS (Life Technologies). Cells were stimulated either electrically with an epoxy-coated bipolar platinum electrode with square suprathreshold electrical stimuli at 1 -2 Hz or optically with light pulses from a 470 nm light-emitting diode (LED; SR-01-B0040 Rebel Star LED assembly; 70 Lm at 700 mA; Luxeonstar, Brantford, Ontario, Canada) mounted 10 mm below the centre of the wells of a 24-well cellculture plate. A specialized stimulus generator (STG 2004) with corresponding software (MC Stimulus II; both from Multichannel Systems, Reutlingen, Germany) was used to perform both electrical and optical stimulation (see also Supplementary material online, Figure S1 ). Irradiance was measured using a PM100D optical power meter (Thorlabs, Munich, Germany) equipped with a S130C slim dual range sensor with the range set at 5 nW-5 mW and the wavelength set at 470 nm. Optical images were captured using a MiCAM ULTIMA-L imaging system (SciMedia, Costa Mesa, CA, USA). Optical pacing was performed by exposure for 10 ms to blue LED light at the maximal irradiance achievable with our setup (0.038 mW/mm 2 ).
Strength -duration curves of optical pacing threshold were constructed by varying pulse duration (5 -25 ms) and irradiance (0.0050 -0.038 mW/ mm 2 ). Reentry was induced by electrical burst pacing with a cycle length of 20 -100 ms. After confirmation of the presence of reentrant arrhythmias, cultures were exposed to blue LED light for 500 ms (at 0.038 mW/mm 2 ).
Specialized software was used for data analysis and construction of activation maps (BrainVision Analyzer 1101; Brainvision, Tokyo, Japan). For baseline shift adjustment during blue LED light exposure, several filters were applied allowing data interpretation during the LED-on period (see Supplementary material online, Figure S1 ). The phase-space method was used to identify and track phase singularities (PSs) of spiral waves as described previously. 16 As measure of wavefront curvature, the straight distance between the spiral wave tip and the point of the first (or second) half winding of the wavefront was determined. 17 To this purpose, a tangent line was drawn along the wavefront in the direct vicinity of the PS (Supplementary material online, Figure S3 , dashed white lines). Next, the length of the normal line from its intersection with the tangent line to its intersection with the wavefront at half of the spiral wave's full winding was measured (Supplementary material online, Figure S3 ).
MEA mapping
To provide additional mechanistic insight into CatCh-mediated effects on spiral waves and to avoid potential complexities associated with the combined application of light-activated potentiometric dyes and ion channels (see also Supplementary material online, Figure S1 ), MEA mapping of extracellular potentials was performed in parallel to optical mapping as a matching non-optical control. For MEA mapping, aCMCs were cultured in fibronectin-coated MEA culture dishes containing 60 30 mm-diameter electrodes with an interelectrode spacing of 200 mm (Multi Channel Systems). Next, reentry was induced by electrical burst pacing as described earlier. During recording, cultures were exposed to blue LED light pulses (10 ms for optical pacing or 500 ms for reentry termination). Electrograms were analysed using MC-Rack software (Multi Channel Systems). 18 
Whole-cell patch-clamp recordings
Voltage-clamp recordings in single LV.CatCh eYFP -transduced aCMCs were carried out in parallel to optical mapping experiments. Transduced cells (identified by their green-yellow fluorescence) were exposed to 10 or 500 ms blue LED light pulses to study CatCh-mediated photocurrents, after reaching GV seal, establishing whole-cell configuration, and setting holding potential at 245 mV. Experiments were performed at 19-238C using a MultiClamp 700B amplifier, a Digidata 1440A A/D converter, Clampex 10.3 software (all from Axon CNS, Molecular Devices, Sunnyvale, CA, USA), the STG 2004 pulse generator with corresponding computer software, and an Axiovert 35 inverted phase-contrast and fluorescence microscope (Carl Zeiss). Cells were bathed in an extracellular solution composed of (in mmol/ L) 137 NaCl, 5 KCl, 1 MgCl 2 , 1.8 CaCl 2 , 10 HEPES, and 11 glucose (pH 7.4 adjusted with NaOH). Patch pipettes manufactured from borosilicate glass with capillary 1.5 mm outer diameter and 1.17 mm inner diameter (Harvard Apparatus, Kent, UK) were pulled by a model P-30 vertical micropipette puller (Sutter Instrument Company, Novato, CA, USA). The internal pipette solution contained (in mmol/L) 20 NaCl, 120 KCl, 1 MgCl 2, 5 EGTA, and 10 HEPES (pH 7.4 adjusted with KOH). Pipettes showed a typical resistance of 2-3 MV and liquid junction potentials ( 5 mV) were corrected. Data were digitized at 10 kHz, filtered at 10 kHz (4-pole Bessel low-pass filter, 24 dB/ octave, 23 dB at cut off) and analysed off-line using pClamp 10 electrophysiology data acquisition and analysis software (Axon CNS, Molecular Devices).
Statistical analysis
Statistical analyses were performed using SPSS11.0 for Windows (SPSS, Chicago, IL, USA). The Mann-Whitney U test or the Wilcoxon signed rank test was used for comparison between groups as indicated. Data were expressed as mean + standard deviation (SD) for a number (n) of observations. Differences were considered statistically significant at P , 0.05.
Results
Characterization of 2D AF model
Immunocytological analysis at Day 8 showed that 100% of the a-actinin Figure 1C ) forming a dense 'syncytial' monolayer ( Figure 1D ), which could be assessed for conduction patterns by optical mapping and by MEA analysis. Typically, no spontaneous activity was observed in the atrial cell cultures. Upon 1 Hz electrical stimulation cultures showed 1:1 uniform convex activation originating from the bipolar pacing electrode, while no PSs were observed ( Figure 1E and G), resembling normal atrial activation as occurs during sinus rhythm. However, after burst pacing, multiple spiral wave reentry circuits and corresponding PSs arose maintaining high-frequency activation (mean 13.8 + 7.0 Hz) independent of any subsequent electrical stimulation ( Figure 1F and H ), resembling activation patterns found in AF.
Confirmation of functional CatCh expression
Atrial cell cultures were transduced with either the lentiviral vector LV.CatCh eYFP encoding a fusion protein between CatCh and eYFP, or the eYFP-encoding lentiviral vector LV.eYFP as a control, to study the effects of CatCh activation on spiral waves (for vector maps, see Figure 2A ). Because transgene expression is driven by a striated muscle-specific promoter, lentiviral vector-transduced atrial cultures showed eYFP signals almost exclusively in the a-actinin + cells (100 + 38.6 vs. 8.7. + Optogenetic arrhythmia termination around 60 kDa (due to fusion of CatCh to the N terminus of eYFP), respectively ( Figure 2E ). Optical and MEA mapping experiments showed that APs could be elicited by optical pacing through exposure to 10 ms light pulses (at 0.038 mW/mm 2 ) in LV.CatCh eYFP -but not in LV.eYFP -transduced cultures (see also Supplementary material online, Figure S2 for a strength-duration analysis of the pacing threshold in LV.CatCh eYFP -transduced cultures), while both culture types could be paced electrically (Figure 3A and B; n ¼ 12 and n ¼ 9, respectively). The maximum change in fluorescence intensity occurred within 12.0 + 8.5 ms (n ¼ 5) throughout the culture ( Figure 3C ), indicating synchronous depolarization of the monolayer by CatCh activation. The functionality of the generated photocurrent was further confirmed in patch-clamp experiments on single aCMCs ( Figure 3D ), which revealed inward currents with a peak current density of 5.31 + 1.13 pA/pF upon exposure to 10 ms blue light pulses (n ¼ 6).
Light-induced spiral wave termination
Exposure to prolonged light pulses (500 ms at 0.038 mW/mm 2 ), producing a sustained current with a peak density of 12.01 + 2.54 pA/pF in single aCMCs (n ¼ 6; Figure 3D ), led to spiral wave termination in all of the LV.CatCh eYFP -(31 out of 31), but none of the LV.eYFPtransduced (0 out of 11) cultures, as judged by optical mapping analyses and confirmed by MEA recordings (Figure 4A-F) . Importantly, LV.CatCh eYFP -transduced cultures that had been subjected to repeated optogenetic spiral wave termination displayed normal uniform conduction upon subsequent electrical activation implying retained excitability ( Figure 4E) . No significant persisting electrophysiological or pro-arrhythmic changes were observed in LV.CatCh.eYFP -transduced cultures following prolonged exposure (i.e. 500 ms) to blue light (see Supplementary material online, Figure S4) . Also, contractility, as judged by phase-contrast microscopy, was retained after expression of CatCh eYFP and its subsequent activation by a 500 ms blue light pulse. During exposure to a 500 ms light pulse, reentry was terminated within 163.1 + 105.8 ms (range 36-444 ms, n ¼ 22) suggesting that reentry could be terminated using pulses shorter than 500 ms. Hence, to find the pulse duration necessary for termination, we induced reentry in LV.CatCh.eYFP -transduced cultures and attempted spiral wave termination by exposure to subsequent blue light pulses of 10, 20, 50, 100, 200, and 500 ms at 0.038 mW/mm 2 . This showed that the average pulse duration necessary for arrhythmia termination was 133.3 + 180.7 ms (n ¼ 6).
Next, we investigated the anti-arrhythmic mechanism underlying arrhythmia termination by CatCh activation. During reentry, a gradient in conduction velocity and AP amplitude was observed. Both parameters decreased near the spiral wave core ( Figure 5A ) while wavefront curvature was significantly higher near the core than in the periphery (the second vs. the doubled first half winding distance of the wavefront was 7.2 + 1.9 vs. 4.1 + 1.1 mm; P , 0.05, n ¼ 6) ( Figure 5B) .
Depolarization by activation of CatCh led to a reduction in overall excitability. The reduction in excitability caused by light-induced depolarization was confirmed by MEA mapping showing a strong decrease in peak-to-peak amplitude [Dpeak-to-peak amplitude 251.3 + 217.1 mV in LV.CatCh eYFP -transduced cultures (n ¼ 6) vs. 9.2 + 9.5 mV in LV.eYFP -transduced cultures (n ¼ 5); Figure 5C and E], likely attributable to inactivation of the fast Na + current. As a consequence, the critical wavefront curvature (the curvature at which the conduction velocity becomes zero, i.e. the curvature near the spiral wave core) was decreased (first half-winding distance was 2.6 + 1.1 before light exposure vs. 5.0 + 2.5 mm during light exposure, n ¼ 6) ( Figure 5F and Supplementary material online, Figure S3 ). Hence, during light exposure, the critical wavefront curvature is reached at a more peripheral point in the wavefront compared with the point of PS (i.e. the point of critical wavefront curvature) before light exposure. Since the source-sink relationship for impulse propagation in cardiac tissue does not allow wavefront curvature to exceed a critical value, spiral wave core size increased after the decrease in excitability during light exposure. This was evinced by a reduction in AP amplitude and inhibition of excitation near the functional core ( Figure 5A ). As a consequence of the lowered critical curvature, culture-wide expansion of the PS trajectory around the growing functional core occurred, which increased the probability of critical collisions of PSs with culture boundaries ( Figure 6A and Supplementary material online, Movie S1) or with PSs of opposite chirality ( Figure 6B and Supplementary material online, Movie S2), ultimately causing spiral wave termination. 
Discussion
The key findings of this study are the following: first, neonatal rat aCMCs can be endowed with functional light-gated cation channels (i.e. CatCh) by lentiviral transduction without evident alterations in the characteristics of the AP or calcium transient. Secondly, activation of these channels by brief light pulses (10 ms/470 nm) provides a depolarizing current strong enough to serve as suprathreshold stimulus for instant and synchronous electrical activation of CatCh-expressing cardiomyocytes in atrial monolayer cultures. Thirdly, in such monolayers, stable rotors with PSs rotating around functional cores and maintaining fibrillatory activation can be terminated effectively and repeatedly by prolonged activation of CatCh (500 ms light exposure). Fourthly, mechanistically, prolonged CatCh activation reduces overall excitability of the fibrillating monolayers, followed by an increase in functional core size, resulting in PS drift, which ultimately leads to termination of the spiral wave arrhythmias. Finally, this is the first study to show that optogenetic engineering of neonatal rat aCMCs, by means of forced CatCh expression and subsequent photoactivation, allows fibrillating aCMC monolayers to generate themselves the electrical current needed for defibrillation. This proof-of-concept may give a strong impetus towards the design of shockless treatment strategies for AF.
Optogenetic control of cardiac excitability
In the past, most studies that aimed to unravel the mechanisms underlying cardiac arrhythmias and to identify new anti-arrhythmic targets relied exclusively on the use of pharmacological and/or electrical interventions to modulate electrophysiological processes in cardiomyocytes, like de-and hyperpolarization. 12, 16, 18 More recently, genetic interventions including site-directed mutagenesis, gene knockdown/knockout and forced (trans)gene expression have been added to the repertoire of techniques to modulate cardiac ion channel activity and excitability in a more refined manner. 11 Nevertheless, even today's most sophisticated genetic interventions allow for only modest spatiotemporal, as well as, quantitative control of the target's functionality. Such constraints hamper further progress in our mechanistic understanding and treatment of cardiac arrhythmias. Optogenetic engineering, however, allows modulation of cellular electrophysiological properties with superb spatiotemporal and quantitative control in a non-voltage-gated fashion by combining the favourable properties of photoactivatable ion channels and light. 6 As a result, optogenetics has become an indispensable tool in neuroscience to modulate the activity of neurons by light and thereby study the functional roles of specific neural pathways in the brain. 6 More recently, optogenetics was introduced in the field of cardiovascular research by showing that channelrhodopsin-2 (ChR2)-expressing cardiomyocytes, either cultured in vitro or present in the intact heart, could be electrically excited by brief light pulses without obvious adverse effects on cardiac function. 7 -9 These pulses caused depolarization of cardiomyocytes at the site of illumination, thereby triggering APs that were rapidly propagated across the cardiac tissue via gap junctions and merged into a spread of uniform electrical activation. Prolonged activation of light-gated cation channels in cardiomyocytes led to sustained depolarization of all cardiomyocytes without causing noticeable adverse effects. 7 However, thus far, the potential of optogenetics to counteract cardiac tachyarrhythmias has not been investigated.
Optogenetic termination of spiral waves
Based on current evidence, reentrant spiral waves play a major role in the maintenance of fibrillation in both atria and ventricles. 19 Hence, most strategies aiming to prevent or terminate AF involve the inhibition of reentry formation and the elimination of existing reentrant circuits, respectively. Previous studies have shown that during reentry, conduction velocity ‡ P , 0.05 vs. LED on using a Wilcoxon signed rank test. a.u., arbitrary units.
Optogenetic arrhythmia termination and excitability gradually increase from the rotor core towards the periphery. Paramount to the establishment of these gradients seem to be the inward rectifier K + current (I K1 ) and the fast Na + current (I Na ), of which the amplitudes decrease towards the rotor core. The interplay between I K1 and I Na determines reentry frequency and rotor stability as a decrease of either current slows and destabilizes the rotor, possibly leading to spiral wave termination. 16, 20, 21 The present study is consistent with this concept, as a light-induced decrease in overall excitability increased the functional core size and terminated reentry. Due to the existing gradient in excitability, decreasing overall excitability will first prevent excitation near the core leading to its expansion thereby causing PS drift from a relatively stable position. Consequently, the chance for PSs to collide with each other or with physical boundaries will increase. Following light-triggered annihilation of all PSs in a culture, as found in our experiments, no spiral waves are generated anymore, allowing reestablishment of a regular cardiac activation pattern. Still, as optogenetic defibrillation is a new field of research, various aspects of this method need to be investigated in further detail in order to fully appraise its value as a research tool and to gain more insight into its therapeutic potential.
Potential advantages over established defibrillation strategies
While pharmacological blockade of I K1 and I Na are well-accepted strategies to terminate reentry, they are associated with proarrhythmia, since the resulting chronic slowing of repolarization and conduction promote afterdepolarizations and reentry, respectively. 16, 22 Optogenetic therapy would, however, decrease excitability only during photostimulation, leaving important electrophysiological parameters unaltered after spiral wave termination. Several advantages of optogenetic therapy over electrical cardiac therapy have been previously postulated in the light of cardiac pacing, including a higher level of spatial control 7, 8 and, more importantly, higher energy efficiency resulting in less tissue damage. For CatCh, the enhanced energy efficiency might be even more pronounced than for earlier ChR2 variants due to its improved light sensitivity. While optical pacing might prove an interesting option for treatment of bradyarrhythmias, energy efficiency could be of even greater importance when trying to normalize heart rhythm during tachyarrhythmia. The possible applicability of optogenetics in the field of tachyarrhythmias was already hinted at in a study showing the ability to cause light-induced conduction block by overexpression of the hyperpolarizing lightsensitive Cl 2 channel NpHR in zebrafish cardiomyocytes. 7 Moreover, using ChR2(H134R), Bruegmann et al. 8 showed that through a depolarizing photocurrent spontaneous beating of embryonic stem cell-derived cardiomyocytes could be depressed, most likely as a result of fast Na + channel inactivation upon prolonged local illumination. In the present study, the possibility to optogenetically suppress cardiac excitability was confirmed by prolonged light exposure of aCMCs expressing the Ca 2+ -permeable and ultra-light-sensitive ChR2 mutant CatCh. The
CatCh-dependent photocurrent was used to show that uniform lightinduced depolarization can terminate spiral wave reentry, exemplifying the possibility to broaden the field of optogenetic control of myocardial function towards arrhythmia termination. In sharp contrast, traditional defibrillation is based on the delivery of high-energy electrical shocks to cause uniform depolarization. The use of high-energy electrical shocks is associated with severe discomfort in patients as well as tissue damage, increasing with stimulus strength and duration. A major improvement in electrical defibrillation has been the introduction of the biphasic waveform 23 and further technical refinements like multistage electrotherapy 24 are arising. Still, stimulus duration in traditional defibrillation must be confined to several milliseconds, whereas the optogenetic approach might enable the use of longer stimuli, such as applied in this study, without inducing tissue damage. During traditional electrical defibrillation, reentry can be re-initiated at critical points in local electrical field strength, when shock strength is below the upper limit of vulnerability or when the shock causes the occurrence of virtual electrodes from which new fibrillatory waves can emanate. 5,25 -27 Since optogenetic defibrillation, as presented in this study, does not use an electric field to induce depolarization, it should not result in re-initiation of fibrillation by the formation of virtual electrodes. Under conditions of homogeneous transduction and illumination also re-initiation as a consequence of aforementioned critical points may be prevented by optogenetic arrhythmia termination. Concordantly, after light-induced spiral wave termination, no proarrhythmic reexcitations were found in our model. Thus, asshown in the present study, optogenetic therapy to controlcardiac function and to terminate arrhythmias might provide several advantages over the traditional means of treating heart rhythm disorders.
Translational considerations and study limitations
This study shows that the endogenous electrochemical gradients present in cardiac tissue can be exploited for defibrillation by optogenetics, as an alternative to the external electrical current applied to interrupt reentrant circuits during conventional electrical defibrillation. 5 However, we acknowledge that translating this principle to the in vivo situation comes with some hurdles that need to be overcome before considering any clinical applications.
First, in the present study, a 2D model of AF was used to demonstrate proof-of-principle for the optogenetic termination of fibrillatory conduction. This in vitro model lacks the complexity found in the intact 3D atrium and thus does not suffer from factors such as a low transduction efficiency of the target cell population and poor light penetration into the target tissue that might limit the effectiveness of optogenetic arrhythmia termination in vivo. Moreover, as we found termination of reentry by light to depend on the collision of PSs with boundaries or with PSs of opposite chirality, at least an area including the PS and its nearest physical boundary or a counteracting PS has to be illuminated for successful arrhythmia termination. However, because in our model the position of the PSs causing reentrant activation cannot be predetermined and their trajectories cannot be controlled, homogeneous illumination of the entire aCMC cultures is required for consistent reentry termination by light. Still, earlier work in the field of ventricular fibrillation has shown that effective defibrillation does not require every cell in the myocardium to be depolarized, 5 hinting at the possibility that successful defibrillation may also be achieved in the case of incomplete light penetration and/or patchy transgene expression. This might even be more pronounced in AF, as rotors or drivers of AF usually localize to specific areas of the atrium such as the direct surroundings of pulmonary vein ostea. Hence, future studies testing the possibility of AF termination using local instead of global cation channel activation may provide an important next step in the realization of shockfree defibrillation in vivo. Nevertheless, in tackling the possibility of insufficient light penetration in vivo, it may be critical to expand the optogenetic toolbox with improved/mutated light-gated cation channels displaying greater light sensitivity or increased ion conductance. In addition, due to the absorption of especially short-wavelength visible light by tissue constituents like blood, it might be of interest to look into (optogenetic) tools that are excited by light of higher wavelength (i.e. near-infrared) or by other energy sources (radio waves/ultrasound) and therefore allow deeper tissue penetration. These improvements are likely to arise in the near future through the ongoing research and advances in (opto)genetic technology. 6, 28 Secondly, it should be noted that the physical boundaries of culture dishes (necessary for extinguishing PSs by collision, in addition to the collision to PSs of opposite chirality) differ from the anatomical boundaries in the intact atrium. Nonetheless, in several clinical studies, PSboundary collisions have been identified as a mechanism of rotor termination in both atrial and ventricular fibrillation. 29, 30 Hence, while in the intact atrium, the likelihood of a PS meeting a PS of opposite chirality may be diminished compared with that in our 2D model, lightinduced rotor termination in vivo might be facilitated by the numerous anatomical boundaries contained within the atrium, such as the many walls of the microvasculature, the mitral/tricuspid valve rings, the ostea of the pulmonary veins, and the epi-and endocardium. Thirdly, in the present study, transgene expression was achieved by lentiviral vector-based gene transfer. Although lentiviral vectors are very efficient in inducing stable transgene expression in vitro, they are of limited use for in vivo cardiac gene therapy mainly because of their poor dissemination through myocardial tissue and their potential to cause insertional oncogenesis. These hurdles may be overcome by using adeno-associated virus (AAV) vectors for in vivo channelrhodopsin gene delivery to the heart as these vectors (i) can mediate long-term transgene expression in post-mitotic cells including cardiomyocytes without the need to integrate their DNA into the target cell genome, (ii) do not contain viral genes encoding potentially cytotoxic and/or immunogenic proteins, (iii) readily spread through myocardial tissue, and (iv) are well known for their excellent in vivo safety. The utility of AAV vectors for in vivo gene transfer to the human heart has been illustrated by a recent clinical study in which heart failure patients received AAV vector particles encoding sarco/endoplasmic reticulum Ca 2+ -ATPase 2a, 31 paving the way for the clinical application of optogenetic and other gene-based therapies in the field of cardiology. Finally, also the delivery method of the necessary light (or any other excitatory energy source) in vivo needs to be perfected. In the field of neurology, solutions to this problem have already been postulated, and lie in the use of, for example, fiberoptics. 32, 33 Hence, the future might hold painfree implantable cardioverter defibrillator device therapy for AF, based on optogenetics and fibreoptic delivery of light, instead of electrical shocks applied via platinum leads, in specific areas of the atrial myocardium.
Without the intention to detract from this prospect, it should be noted that the conclusions drawn from the present study are only conceptual in relation to human AF and therefore cannot be readily extrapolated to the clinical setting. Hence, there is still a considerable amount of work to be done before optogenetic therapy (or any other therapy exploiting the electrochemical gradients that are endogenously present in myocardial tissue) becomes a realistic treatment option for patients with cardiac rhythm disorders.
Conclusions
In summary, forced expression of the light-gated cation channel CatCh in aCMCs allows for effective and repeated termination of reentrant conduction by photocurrent-induced functional core expansion. These results indicate that optogenetic control of cardiac electrical function could serve as a novel anti-arrhythmic strategy, in which the arrhythmogenic substrate itself provides the defibrillating current. This may trigger the exploration of a previously uninvestigated principle to develop safe and effective new therapies for cardiac arrhythmias.
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